Overview

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients with wet AMD.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Criteria
Inclusion Criteria:

- AMD disease

Exclusion Criteria:

- Age